Zevra Therapeutics, Inc. Non-GAAP EPS of -$0.06 misses by $1.44, revenue of $25.88M beats by $3.39M

2 hours ago 1

Zevra Therapeutics, Inc. press release (NASDAQ:ZVRA): Q2 Non-GAAP EPS of -$0.06 misses by $1.44.
Revenue of $25.88M (+481.6% Y/Y) beats by $3.39M.

Recommended For You